Antoni Ribas
Antoni Ribas is a renowned oncologist and researcher at the Vall d’Hebron Institute of Oncology in Barcelona, Spain. He played a significant role in the early clinical trials of Keytruda, contributing to its development and approval as a revolutionary treatment for advanced melanoma and other cancers.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Spain | 1 | 7.00 | 0.04% | +0% | 46,754,778 | 18,620 | $1,400,000 | 558$ |
| Totals | 1 | 46,754,778 | 18,620 | $1,400,000 | 558$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Spain:
Antoni Ribas played a key role in the early phases of the development of pembrolizumab.
7